9 completed, 3 withdrawn, 1 recruiting, 1 terminated. 7 Phase 3, 6 Phase 2, 2 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 4, Withdrawn 2, Terminated 1 |
| Phase 2 | 6 | Completed 4, Recruiting 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 4 | 1 | Completed 1 |
Follow peramivir: new trials by email Literature Review of peramivir trials Research Report on peramivir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza Oseltamivir, Favipiravir, Zanamivir - Influenza, Influenza, Human | Phase 2 | Recruiting | University of Oxford | 3000 | 2023-02-22 | 2026-04-14 |
| Safety, PK and Effectiveness of IV Peramivir in Elderly and Higher Risk Subjects With Uncomplicated Influenza Peramivir - Influenza | Phase 3 | Completed | BioCryst Pharmaceuticals | 74 | 2015-12-01 | 2021-03-23 |
| ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir Oseltamivir, Peramivir - Influenza | Phase 4 | Completed | Johns Hopkins University | 180 | 2015-11-01 | 2019-10-04 |
| Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza Peramivir, Oseltamivir - Influenza | Phase 3 | Completed | BioCryst Pharmaceuticals | 137 | 2015-03-11 | 2021-03-23 |
| Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections Peramivir - Influenza | Phase 2 / Phase 3 | Completed | Chinese University of Hong Kong | 16 | 2011-02-01 | 2016-01-29 |
| A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza. Peramivir, Placebo Comparator - Influenza | Phase 3 | Withdrawn | BioCryst Pharmaceuticals | 2010-10-01 | 2026-06-10 | |
| Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza Peramivir - Seasonal Influenza, Cough | Phase 3 | Completed | BioCryst Pharmaceuticals | 234 | 2009-10-01 | 2015-02-12 |
| A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza Peramivir, Placebo - Acute, Uncomplicated Human Influenza | Phase 2 | Completed | BioCryst Pharmaceuticals | 405 | 2008-07-01 | 2015-02-16 |
| Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza Peramivir, Placebo - Influenza | Phase 3 | Terminated | BioCryst Pharmaceuticals | 82 | 2008-01-01 | 2021-03-17 |
| Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza Peramivir 200 mg, Peramivir 400 mg, Oseltamivir - Influenza | Phase 2 | Completed | BioCryst Pharmaceuticals | 137 | 2007-07-01 | 2015-02-12 |
| Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza. Peramivir 150 mg, Peramivir 300 mg, Placebo - Influenza | Phase 2 | Completed | BioCryst Pharmaceuticals | 344 | 2007-01-01 | 2015-02-12 |
| Safety and Dose Study of Peramivir for Influenza Treatment Peramivir - Influenza | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 100 | 2006-02-23 | 2017-07-02 |
| Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza Peramivir - Influenza | Phase 1 / Phase 2 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-11-11 | ||
| Intramuscular Peramivir for the Treatment of Uncomplicated Influenza Peramivir 150mg, Peramivir 300mg - Influenza | Phase 3 | Withdrawn | BioCryst Pharmaceuticals | 2026-06-01 |
Influenza, Human (13) · Cough (1) · Emergencies (1) · Fatigue (1) · Headache (1) · Influenza in Birds (1) · Myalgia (1) · Nasal Obstruction (1) · Pharyngitis (1) · Virus Diseases (1)
BioCryst Pharmaceuticals (9) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Chinese University of Hong Kong (1) · Johns Hopkins University (1) · University of Oxford (1)
United States (11) · Australia (3) · Canada (3) · New Zealand (3) · South Africa (3) · Brazil (1) · China (1) · Hong Kong (1) · Laos (1) · Mexico (1) · Nepal (1) · Puerto Rico (1) · Singapore (1) · Thailand (1)
Alain Martel, MD (1) · Allan Kelly, MD (1) · Balbir Chahal, MD (1) · Barry Packman, MD (1) · Ben Lasko, MD (1) · Bernardo Ng, MD (1) · Bruce Berwald, MD (1) · Bruce D. Forney, MD (1) · Carol Clark, MD (1) · Chivers Woodruff, Jr., MD (1) · Dan C Henry, MD (1) · Daniel Shu, MD (1) · David L. Fried, MD (1) · David Parenti, MD (1) · Dennis Mikolich, MD (1)
PMID 23111657, PMID 23985625, PMID 42520824
N01AI30025 (1)